EU regulator pulls diabetes drug Avandia over health fears
The European Medicines Agency said Thursday that diabetes drug Avandia would no longer be available to patients in Europe after recommending that it be removed from the market due to health concerns.
Avandia "will stop being available in Europe within the next few months", the EMA said in a statement.
The announcement came as the US Food and Drug Administration decided to severely restrict the use of Avandia, made by British company GlaxoSmithKline, but stopped short of an outright ban.
© 2010 AFP